HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delayed progression of murine AIDS in C57BL/6 mice pre-immunized with a highly antigenic 10-mer peptide encoded by the murine AIDS defective virus gag p12 gene.

Abstract
C57BL/6 (B6) mice were immunized with a highly antigenic 10-mer peptide (P12-10), which is encoded by the murine AIDS (MAIDS) defective virus gag p12 gene, emulsified in incomplete Freund's adjuvant (ICFA). One week later, the mice were inoculated with the MAIDS virus to see if the immunization affects progression of MAIDS. It was demonstrated that the immunization significantly delayed progression of MAIDS, although it failed to induce appreciable cytotoxic T lymphocyte (CTL) responses against the P12-10 antigen. In contrast, immunization of B6 mice with the P12-10 coupled with liposome induced substantial CTL responses but failed to protect the mice against MAIDS development. This segregation between CTL activity and in vivo protection efficacy might be worth considering when we exploit vaccines for augmenting cellular immunity mediated by CD8+ T cells.
AuthorsT Mizuochi, A Horino, T Uchida
JournalVaccine (Vaccine) Vol. 16 Issue 20 Pg. 2026-30 (Dec 1998) ISSN: 0264-410X [Print] Netherlands
PMID9796060 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Gene Products, gag
  • Histocompatibility Antigens Class I
  • Lipids
  • Liposomes
  • incomplete Freund's adjuvant
  • Freund's Adjuvant
Topics
  • Animals
  • Defective Viruses (chemistry, immunology, pathogenicity)
  • Disease Progression
  • Freund's Adjuvant (immunology)
  • Gene Products, gag (genetics, immunology, pharmacology)
  • Histocompatibility Antigens Class I (immunology)
  • Leukemia Virus, Murine (chemistry, immunology)
  • Lipids
  • Liposomes (immunology)
  • Mice
  • Mice, Inbred C57BL
  • Murine Acquired Immunodeficiency Syndrome (immunology)
  • T-Lymphocytes, Cytotoxic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: